News from Adapt Pharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 03, 2017, 07:00 ET Adapt Pharma® Presents Human Factors Study Data on Usability of NARCAN® (naloxone HCl) Nasal Spray at the 41st Association for Medical Education & Research in Substance Abuse Annual National Conference

Adapt Pharma, Inc. (www.adaptpharma.com) presented findings from two human factors studies conducted, as a part of its Food and Drug Administration...


Oct 09, 2017, 07:00 ET Adapt Pharma® Announces Partnership With New York To Provide NARCAN® (naloxone HCl) Nasal Spray 4mg

Adapt Pharma, Inc. (www.adaptpharma.com) today announced a partnership with the New York State Department of Health, New York City Health...


Jun 20, 2017, 07:00 ET Adapt Pharma Acknowledges the U.S. Drug Enforcement Administration (DEA) New Guidance to First Responders on the Hazards of Exposure to Fentanyl

Police officers and first responders in multiple states, including Ohio, Maryland, and Pennsylvania, have overdosed due to accidental exposure to...


Jun 12, 2017, 16:31 ET Adapt Pharma Presents Human Factors Study Data at 2017 International Conference on Opioids

Adapt Pharma today presented findings from two human factors studies conducted, as a part of U.S. product approval, to evaluate the usability of...


Jun 06, 2017, 09:00 ET Survey Data Published on Community Use of NARCAN® (naloxone HCI) Nasal Spray 4 mg to Help Reverse Opioid-Related Overdose - Current Medical Research and Opinion Journal

Adapt Pharma (www.AdaptPharma.com) announces recent publication of survey data analyzing community use of NARCAN® Nasal Spray 4 mg. The manuscript,...


Apr 10, 2017, 13:00 ET Adapt Pharma Expands Free NARCAN® Nasal Spray Program to U.S. Colleges and Universities

Adapt Pharma, Limited (Adapt Pharma) announced today that it will donate 20,000 cartons (40,000 doses) of NARCAN® (naloxone hydrochloride) Nasal...


Mar 16, 2017, 18:00 ET New Data Presented on Adapt Pharma's Community Use of Narcan® Nasal Spray 4 mg to Reverse Opioid-Related Overdose

Adapt Pharma (www.AdaptPharma.com) today presented results of a survey conducted with Police and Community Organizations describing real-world...


Feb 28, 2017, 08:00 ET Adapt Pharma Marks One-Year Anniversary of NARCAN® Nasal Spray (naloxone HCl) 4mg Launch in the United States

Since February 2016, NARCAN® Nasal Spray has become the leading naloxone product available for community use for the emergency treatment of known...


Feb 21, 2017, 08:02 ET Adapt Pharma Announces European Marketing Application Filed For Naloxone Hydrochloride Nasal Spray

Adapt Pharma Limited (Adapt Pharma) today announced that a marketing application for Naloxone Hydrochloride (HCl) Nasal Spray for the treatment of...


Jan 25, 2017, 08:34 ET NARCAN® (naloxone HCl) Nasal Spray 2mg Approved by U.S. Food and Drug Administration (FDA)

Today, the U.S. Food and Drug Administration (FDA) approved NARCAN® Nasal Spray as a 2mg formulation for the emergency treatment of known or...


Nov 22, 2016, 14:56 ET Adapt Pharma Welcomes U.S. Food and Drug Administration Consumer Update Regarding Opioids

Adapt Pharma welcomes the U.S. Food and Drug Administration's (FDA) Consumer Update What to Ask Your Doctor Before Taking Opioids. Adapt applauds...


Oct 06, 2016, 09:00 ET FDA Joint Meeting of Advisory Committees Recommends Commitment to Higher Doses and Broader Access for Naloxone to Help in Fight Against Opioid Overdose

 Adapt Pharma Limited (Adapt Pharma) participated in yesterday's joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee...


Oct 05, 2016, 07:00 ET Adapt Pharma Announces NARCAN® coverage with California's Medi-Cal Program

 Effective October 1, 2016, the Medi-Cal Fee-For-Service program provides unrestricted, $0 copay access to NARCAN® Nasal Spray for its...


Oct 03, 2016, 15:51 ET Health Canada Approves Adapt Pharma's Naloxone Hydrochloride Nasal Spray to Treat Opioid Overdose

 Health Canada today granted approval for naloxone hydrochloride nasal spray, which is indicated for emergency use outside of a hospital to...


Sep 20, 2016, 07:00 ET Newly Published Study Finds NARCAN® Nasal Spray's Concentrated Formulation Rapidly Delivers an Effective Naloxone Dose and is Readily Usable by the General Public

 A new study released in The Journal of Clinical Pharmacology finds that the newly Food and Drug Administration (FDA) approved intranasal (IN)...


Jul 12, 2016, 10:00 ET Adapt Pharma to Launch Program to Raise Awareness, Expand Access and Facilitate Product Experience of NARCAN® (Naloxone HCl) Nasal Spray - a new Treatment for Opioid Overdose

Adapt Pharma, Limited, (www.adaptpharma.com) today announced that it has launched a program providing a donation of 25,000 cartons (50,000 doses)...


Apr 28, 2016, 08:00 ET Adapt Pharma Teams with Smith Medical Partners to Support Distribution of Free NARCAN® (Naloxone HCl) Nasal Spray Offer to All U.S. High Schools

 Adapt Pharma, Limited (www.adaptpharma.com), today announced Smith Medical Partners, LLC (www.smpspecialty.com), as their distribution partner...


Apr 14, 2016, 08:00 ET Introducing the NARCAN® Now App, a smartphone application providing opioid overdose recognition education and treatment instructions

Adapt Pharma, Limited, (www.adaptpharma.com) today announced the launch of a new smartphone app, NARCAN® Now. This free app provides guidance...


Feb 25, 2016, 16:32 ET NARCAN® (Naloxone Hydrochloride) NASAL SPRAY Now Available in the United States for Emergency Treatment of Known or Suspected Opioid Overdose

 Adapt Pharma, Limited (www.adaptpharma.com) today announced the United States (U.S.) commercial availability of opioid antagonist NARCAN®...